Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
International Journal of STD & AIDS
|
June 17, 2026
Long-acting injectable cabotegravir/rilpivirine in a pregnant woman living with HIV with hyperemesis gravidarum:a case report and review of literature
Emanuela Lattuada, Andrea Delama, Alessandro Castelli, et al.
Le Infezioni in Medicina
|
October 20, 2009
[Efficacy and safety of TAM-sparing antiretroviral regimens in naïve HIV-positive patients]
Martina Gottardi, Massimiliano Lanzafame, Emanuela Lattuada, et al.
AIDS Research and Human Retroviruses
|
August 8, 2023
Short Cycle, Intermittent Therapy: A Valuable Option in Selected, Virologically Suppressed People Living with HIV
Massimiliano Lanzafame, Emanuela Lattuada, Dora Luise, et al.
Le Infezioni in Medicina
|
March 17, 2004
Acute mediastinitis: a severe complication of transdermal therapy in a patient with ischaemic heart disease. A case report
Federica Faggian, Emanuela Lattuada, Massimiliano Lanzafame, et al.
Acta Bio-Medica : Atenei Parmensis
|
June 29, 2010
Optimal fosamprenavir regimen to prevent lipid abnormalities
Emanuela Lattuada, Massimiliano Lanzafame, Carmela Grosso, et al.
Southern Medical Journal
|
April 28, 2004
Histoplasmosis in two human immunodeficiency virus-positive immigrants to Italy: clinical features and management in the highly active antiretroviral therapy era
Federica Faggian, Massimiliano Lanzafame, Emanuela Lattuada, et al.
The Journal of Infection
|
July 26, 2005
Cutaneous abscess due to Eubacterium lentum in injection drug user: a case report and review of the literature
Emanuela Lattuada, Antonella Zorzi, Massimiliano Lanzafame, et al.
International Journal of STD & AIDS
|
April 20, 2019
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study
Sebastiano Rizzardo, Massimiliano Lanzafame, Emanuela Lattuada, et al.
International Journal of STD & AIDS
|
October 30, 2016
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient
Massimiliano Lanzafame, Emanuela Lattuada, Stefano Nicolè, et al.
Journal of Medical Case Reports
|
July 24, 2019
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report
Sheila Chiesi, Sebastiano Rizzardo, Daniela Piacentini, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
International Journal of STD & AIDS
|
June 17, 2026
Long-acting injectable cabotegravir/rilpivirine in a pregnant woman living with HIV with hyperemesis gravidarum:a case report and review of literature
Emanuela Lattuada, Andrea Delama, Alessandro Castelli, et al.
Le Infezioni in Medicina
|
October 20, 2009
[Efficacy and safety of TAM-sparing antiretroviral regimens in naïve HIV-positive patients]
Martina Gottardi, Massimiliano Lanzafame, Emanuela Lattuada, et al.
AIDS Research and Human Retroviruses
|
August 8, 2023
Short Cycle, Intermittent Therapy: A Valuable Option in Selected, Virologically Suppressed People Living with HIV
Massimiliano Lanzafame, Emanuela Lattuada, Dora Luise, et al.
Le Infezioni in Medicina
|
March 17, 2004
Acute mediastinitis: a severe complication of transdermal therapy in a patient with ischaemic heart disease. A case report
Federica Faggian, Emanuela Lattuada, Massimiliano Lanzafame, et al.
Acta Bio-Medica : Atenei Parmensis
|
June 29, 2010
Optimal fosamprenavir regimen to prevent lipid abnormalities
Emanuela Lattuada, Massimiliano Lanzafame, Carmela Grosso, et al.
Southern Medical Journal
|
April 28, 2004
Histoplasmosis in two human immunodeficiency virus-positive immigrants to Italy: clinical features and management in the highly active antiretroviral therapy era
Federica Faggian, Massimiliano Lanzafame, Emanuela Lattuada, et al.
The Journal of Infection
|
July 26, 2005
Cutaneous abscess due to Eubacterium lentum in injection drug user: a case report and review of the literature
Emanuela Lattuada, Antonella Zorzi, Massimiliano Lanzafame, et al.
International Journal of STD & AIDS
|
April 20, 2019
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study
Sebastiano Rizzardo, Massimiliano Lanzafame, Emanuela Lattuada, et al.
International Journal of STD & AIDS
|
October 30, 2016
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient
Massimiliano Lanzafame, Emanuela Lattuada, Stefano Nicolè, et al.
Journal of Medical Case Reports
|
July 24, 2019
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report
Sheila Chiesi, Sebastiano Rizzardo, Daniela Piacentini, et al.
Page
of 4